Surgery-ineligible elderly patients with cutaneous squamous cell carcinoma of the head and neck region gain clinical benefit from definitive weekly hypofractionated radiotherapy.
Francesca De FeliceMaria SerponeCarlo Guglielmo CattaneoFederico Di GiammarcoAlberto FallicoAlessia Delle DonneMaura LanzilaoElisa VittiFrancesco MaramponDaniela MusioVincenzo TomboliniGiuseppe MinnitiPublished in: Head & neck (2023)
Our study confirmed the satisfying efficacy and acceptable toxicity of definitive weekly hypofractionated RT for cHNSCC in elderly patients. Our results establish weekly hypofractionated scheduleas a promising treatment option for elderly patients with cHNSCC.